Lexology July 1, 2022
The United States Supreme Court recently issued its decision in Dobbs v. Jackson Women’s Health Org., ––– U.S. –––, 2022 WL 2276808 (2022), overturning Roe v. Wade, 410 U.S. 113 (1973), and Planned Parenthood of Southeastern Pennsylvania v. Casey, 505 U.S. 833 (1992). In holding that the U.S. Constitution does not protect a right to abortion, the court “returned” regulating abortion to the individual states. Aside from the obvious systematic implications of the decision, Dobbs has now created various challenges for pharmaceutical retailers and their ability to comply with Health Insurance Portability and Accountability Act (“HIPAA”) privacy requirements.
Key Considerations for Pharmaceutical Retailers and Beyond
HIPAA is a comprehensive federal law that created national standards to prevent certain health information...
Today's Sponsors
Today's Sponsor